Integrated Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, Colorado, USA.
Nat Immunol. 2010 Mar;11(3):225-31. doi: 10.1038/ni.1844. Epub 2010 Feb 7.
Autoreactive CD4(+) T cells are involved in the pathogenesis of many autoimmune diseases, but the antigens that stimulate their responses have been difficult to identify and in most cases are not well defined. In the nonobese diabetic (NOD) mouse model of type 1 diabetes, we have identified the peptide WE14 from chromogranin A (ChgA) as the antigen for highly diabetogenic CD4(+) T cell clones. Peptide truncation and extension analysis shows that WE14 bound to the NOD mouse major histocompatibility complex class II molecule I-A(g7) in an atypical manner, occupying only the carboxy-terminal half of the I-A(g7) peptide-binding groove. This finding extends the list of T cell antigens in type 1 diabetes and supports the idea that autoreactive T cells respond to unusually presented self peptides.
自身反应性 CD4(+)T 细胞参与许多自身免疫性疾病的发病机制,但刺激其反应的抗原一直难以确定,在大多数情况下也没有很好地定义。在 1 型糖尿病的非肥胖型糖尿病(NOD)小鼠模型中,我们已经确定了嗜铬粒蛋白 A(ChgA)中的肽 WE14 是高度致糖尿病性 CD4(+)T 细胞克隆的抗原。肽截断和扩展分析表明,WE14 以非典型方式与 NOD 小鼠主要组织相容性复合体 II 类分子 I-A(g7)结合,仅占据 I-A(g7)肽结合槽的羧基末端一半。这一发现扩展了 1 型糖尿病中的 T 细胞抗原列表,并支持自身反应性 T 细胞对异常呈现的自身肽作出反应的观点。
Nat Immunol. 2010-2-7
Proc Natl Acad Sci U S A. 2015-10-27
J Autoimmun. 2013-11-13
Immunol Cell Biol. 2025-8
NPJ Syst Biol Appl. 2025-1-17
Front Immunol. 2024
Nat Methods. 2024-5
Acta Pharmacol Sin. 2024-4
Regul Pept. 2008-11-29
Diabetes. 2008-5
Amino Acids. 2007-8
J Clin Invest. 2006-8